Abstract
Objective: To report a case of Neuropathy, Encephalopathy, Myasthenia Gravis and Lambert Eaton Myasthenic Syndrome in a patient with neuroendocrine lung cancer.
Background Case reports of combined Myasthenia Gravis(MG) and Lambert-Eaton Myasthenic Syndrome(LEMS) have been reported with small cell lung cancer but never been reported in Large Cell NeuroEndocrine Cancer(LCNEC) in English literature. We describe the first case of MG, LEMS and demyelinating neuropathy in a patient with LCNEC of lung and response to intravenous immunoglobulin (IVIG) treatment.
Design/Methods: case report and review of literature.
Results: A 64-year-female with LCNEC(stage-1A) status post wedge resection presented with one week history of encephalopathy, diplopia, generalized weakness and paresthesia. She had autonomic instability reflected by wide fluctuation in her blood pressure. Examination showed external ophthalmoplegia, facial diplegia and proximal 2/5, distal 4/5 strength with areflexia. She was intubated secondary to neuromuscular weakness. EEG showed moderate encephalopathy. MRI of brain and cerebrospinal fluid analysis were unremarkable. Electrophysiological studies revealed severe sensorimotor demyelinating polyneuropathy. Repetitive nerve stimulation showed decremental response of > 20%. She also had positive acetylcholine receptor binding antibody and voltage gated calcium channel antibody. An extensive paraneoplastic panel was negative. Anti-Gq1b antibody was negative. Immunoperoxidase staining of lung biopsy was positive for CD-15, TTF-1, CK-7 and CAM 6.2. Patient received 2 courses of IVIG 2 gm/ kg with rapid recovery. Follow- up showed mild right upper extremity weakness and ataxia. She did not have any recurrence of symptoms in a 2 year follow- up.
Conclusions: This is an unusual paraneoplastic manifestation of LCNEC lung cancer where patient presented with features of MG, LEMS and demyelinating neuropathy at the same time with very good response to IVIG. A combination of encephalopathy, ophthalmoplegia, areflexia and demyelinating neuropathy also suggests Bickerstaff Encephalitis(BE) despite negative anti-Gq1b antibody(32% negative anti-Gq1b antibody in BE). Multiple antibodies targeting different receptors may underlie pathology.
Disclosure: Dr. Neelam has nothing to disclose. Dr. Lim has nothing to disclose. Dr. Singh has nothing to disclose.
Wednesday, April 25 2012, 07:30 am-12:00 pm
- Copyright © 2011 by AAN Enterprises, Inc.
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.